Literature DB >> 9360522

Thyrotropin-receptor and thyroid peroxidase-specific T cell clones and their cytokine profile in autoimmune thyroid disease.

M E Fisfalen1, E M Palmer, G A Van Seventer, K Soltani, Y Sawai, E Kaplan, Y Hidaka, C Ober, L J DeGroot.   

Abstract

We studied the cytokine profile and the immune responses to thyroid antigens of specific T cell clones (TCC) isolated from patients with Hashimoto's thyroiditis (HT) and Graves' disease (GD). Antigen-specific TCC were reactive to thyroid peroxidase (TPO), thyroglobulin (Tg) or human recombinant TSH-receptor extracellular domain (TSH-R), and/or their respective peptides. Of the 43 clones derived from HT patients, 65% were reactive to TPO, and 59% of the 32 clones derived from GD patients were reactive to TSH-R. TPO epitopes 100-119 and 625-644 were recognized by 75% of HT-derived clones, whereas TSH-R epitopes 158-176, 207-222, and 343-362/357-376 were recognized by 85% of GD-derived TCC. The TCC were classified according to their cytokine profile into T helper cell (Th)0 [secreting interleukin (IL)-4, IL-5, interferon (IFN)-gamma], Th1 (secreting IFN-gamma) and Th2 (secreting IL-4 and/or IL-5). Tumor necrosis factor-beta and IL-10 were produced by all subsets. The specific TCC were predominantly Th1-like cells in HT, and were Th0- and Th1-like cells in GD. Fifty three percent of Th0 clones were derived from GD patients and were reactive to TSH-R, whereas 50% of Th1 clones were derived from HT patients and were reactive to TPO or Tg. Most Th2 clones (82%) were reactive to TPO and were established from peripheral blood. All these clones produced IL-5, and 64% produced IL-4 and IL-10. Interestingly, IFN-gamma was highly produced by TPO- or Tg-specific clones established from HT thyroid tissue. These results confirm at the clonal level our previous studies regarding T cell epitopes on TPO and TSH-R molecules and support the concept that immunodominant T cell epitopes are located on amino acid residues 100-119 and 625-644 of TPO in HT and amino acid residues 158-176, 207-222 and 343-362/357-376 of TSH-R in GD. Our studies also demonstrate that thyroid-specific T cells can be classified into Th0, Th1, and Th2 subsets. TPO- or Tg-specific clones with Th1 phenotype appear to be involved in the pathogenesis of HT, mediating thyroid tissue destruction, whereas TSH-R clones with Th0 phenotype may induce thyroid-stimulating autoantibodies in GD.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9360522     DOI: 10.1210/jcem.82.11.4336

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  10 in total

1.  Long-term immunological study in Graves' disease treated with thyroid arterial embolization.

Authors:  Wei Zhao; Bu-Lang Gao; Cang-Zheng Jin; Gen-Fa Yi; Hui-Ying Yang; Hong Li; Dian-Ping Song; Ji-Hong Hu; Yong-Neng Jiang
Journal:  J Clin Immunol       Date:  2008-07-17       Impact factor: 8.317

2.  Cepharanthine blocks TSH receptor peptide presentation by HLA-DR3: Therapeutic implications to Graves' disease.

Authors:  Cheuk Wun Li; Roman Osman; Francesca Menconi; Erlinda Concepcion; Yaron Tomer
Journal:  J Autoimmun       Date:  2020-01-21       Impact factor: 7.094

3.  T cells expanded in presence of IL-15 exhibit increased antioxidant capacity and innate effector molecules.

Authors:  Navtej Kaur; Osama S Naga; Håkan Norell; Amir A Al-Khami; Matthew J Scheffel; Nitya G Chakraborty; Christina Voelkel-Johnson; Bijay Mukherji; Shikhar Mehrotra
Journal:  Cytokine       Date:  2011-05-23       Impact factor: 3.861

4.  A double conundrum: concurrent presentation of Hashimoto's thyroiditis and ulcerative colitis.

Authors:  Gurpreet Singh; Susie Brien; Ellen Taylor
Journal:  BMJ Case Rep       Date:  2016-04-22

5.  Increased interleukin-4-positive lymphocytes in patients with Hashimoto's thyroiditis and concurrent non-endocrine autoimmune disorders.

Authors:  M G Santaguida; S Nardo; S C Del Duca; E Lococo; C Virili; L Gargano; L Lenti; M Centanni
Journal:  Clin Exp Immunol       Date:  2011-05-30       Impact factor: 4.330

Review 6.  Breaking tolerance to thyroid antigens: changing concepts in thyroid autoimmunity.

Authors:  Sandra M McLachlan; Basil Rapoport
Journal:  Endocr Rev       Date:  2013-12-04       Impact factor: 19.871

7.  Dendritic cells infected with adenovirus expressing the thyrotrophin receptor induce Graves' hyperthyroidism in BALB/c mice.

Authors:  M Kita-Furuyama; Y Nagayama; P Pichurin; S M McLachlan; B Rapoport; K Eguchi
Journal:  Clin Exp Immunol       Date:  2003-02       Impact factor: 4.330

8.  Evaluation of T cell stimulation by thyrotropin-receptor epitopes in Graves' disease.

Authors:  L J De Groot; Y Ha Shin; D Pan; G Gopalakrishnan; J V Hennessey
Journal:  J Endocrinol Invest       Date:  2009-01       Impact factor: 4.256

9.  Symptomatic empty sella syndrome: an unusual manifestation of Erdheim-Chester disease.

Authors:  Wann Jia Loh; Kesavan Sittampalam; Suan Cheng Tan; Manju Chandran
Journal:  Endocrinol Diabetes Metab Case Rep       Date:  2015-03-01

Review 10.  Thyrotropin Receptor Blocking Antibodies.

Authors:  Tanja Diana; Paul D Olivo; George J Kahaly
Journal:  Horm Metab Res       Date:  2018-10-04       Impact factor: 2.936

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.